These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38057319)

  • 1. Docking for EP4R antagonists active against inflammatory pain.
    Gahbauer S; DeLeon C; Braz JM; Craik V; Kang HJ; Wan X; Huang XP; Billesbølle CB; Liu Y; Che T; Deshpande I; Jewell M; Fink EA; Kondratov IS; Moroz YS; Irwin JJ; Basbaum AI; Roth BL; Shoichet BK
    Nat Commun; 2023 Dec; 14(1):8067. PubMed ID: 38057319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-Specific Actions of the Prostaglandin E-Prostanoid Receptor 4 Attenuating Hypertension: A Dominant Role for Kidney Epithelial Cells Compared With Macrophages.
    Yang T; Song C; Ralph DL; Andrews P; Sparks MA; Koller BH; McDonough AA; Coffman TM
    J Am Heart Assoc; 2022 Oct; 11(19):e026581. PubMed ID: 36172956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prostaglandin EP4 receptor is a master regulator of the expression of PGE
    Kashmiry A; Tate R; Rotondo G; Davidson J; Rotondo D
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1297-1304. PubMed ID: 30053598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 accelerates invasion by upregulating Snail in hepatocellular carcinoma cells.
    Zhang M; Zhang H; Cheng S; Zhang D; Xu Y; Bai X; Xia S; Zhang L; Ma J; Du M; Wang Y; Wang J; Chen M; Leng J
    Tumour Biol; 2014 Jul; 35(7):7135-45. PubMed ID: 24760275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E
    Xie T; Zhang Z; Cui Y; Shu Y; Liu Y; Zou J; Wang M; Wang Y; Yang Q; Pan X; Cai J; Sun X; Yao Y; Wang X
    Exp Eye Res; 2021 Apr; 205():108507. PubMed ID: 33609510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
    Paul AG; Chandran B; Sharma-Walia N
    Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and characterization of lead compounds as anti-inflammatory drugs targeting mPGES-1 via enzymelink screening.
    Lu R; Akasaka H; Ruan KH
    Future Med Chem; 2023 May; 15(9):757-767. PubMed ID: 37248701
    [No Abstract]   [Full Text] [Related]  

  • 8. Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory Properties.
    Ganesh T; Banik A; Dingledine R; Wang W; Amaradhi R
    Mol Pharm; 2018 Dec; 15(12):5809-5817. PubMed ID: 30398879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multitargeting of selected prostanoid receptors provides agents with enhanced anti-inflammatory activity in macrophages.
    Wang JW; Woodward DF; Martos JL; Cornell CL; Carling RW; Kingsley PJ; Marnett LJ
    FASEB J; 2016 Jan; 30(1):394-404. PubMed ID: 26420849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti-inflammatory effects.
    Woodward DF; Wang JW; Ni M; Bauer A; Martos JL; Carling RW; Poloso NJ
    FASEB J; 2017 Jan; 31(1):368-375. PubMed ID: 27770021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of cyclooxygenase-2 expression in cultured microglia by prostaglandin E2, cyclic AMP and non-steroidal anti-inflammatory drugs.
    Minghetti L; Polazzi E; Nicolini A; Créminon C; Levi G
    Eur J Neurosci; 1997 May; 9(5):934-40. PubMed ID: 9182946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs.
    Cryer B; Feldman M
    Am J Med; 1998 May; 104(5):413-21. PubMed ID: 9626023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of alkaloidal and glycosidal fractions from leaves of Trigonella foenum-graecum L. cv. Desi indigenous to Pakistan for antiprostaglandin evaluation as substitute of nonsteroidal anti-inflammatory drugs.
    Shaukat TM; Omer MO; Javeed A; Rehman HU; Shaukat TM
    J Ethnopharmacol; 2023 Dec; 317():116730. PubMed ID: 37336337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.
    Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D
    J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin Ameliorates the Reduction Effect of PGE2 on Fibrillar β-Amyloid Peptide (1-42)-Induced Microglial Phagocytosis through the Inhibition of EP2-PKA Signaling in N9 Microglial Cells.
    He GL; Luo Z; Yang J; Shen TT; Chen Y; Yang XS
    PLoS One; 2016; 11(1):e0147721. PubMed ID: 26824354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Selective Prostaglandin E2 Synthesis Inhibitor Relieves Pyrexia and Chronic Inflammation in Rats.
    Sugita R; Kuwabara H; Sugimoto K; Kubota K; Imamura Y; Kiho T; Tengeiji A; Kawakami K; Shimada K
    Inflammation; 2016 Apr; 39(2):907-15. PubMed ID: 26923147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase 2 expression by endothelin-1-stimulated mouse resident peritoneal macrophages in vitro.
    Shimada K; Yonetani Y; Kita T; Suzumura A; Takayanagi T; Nakashima T
    Eur J Pharmacol; 1998 Aug; 356(1):73-80. PubMed ID: 9761426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of aspirin-mediated eosinophil activation by prostaglandin E
    Pal K; Ramsden M; Shim YM; Borish L; Payne SC; Steinke JW
    Ann Allergy Asthma Immunol; 2019 Nov; 123(5):503-506. PubMed ID: 31513909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease of urinary prostaglandin E2 and prostaglandin F2 alpha excretion by nonsteroidal anti-inflammatory drugs in rats. Relationship to anti-inflammatory activity.
    Matsuda K; Ohnishi K; Misaka E; Yamazaki M
    Biochem Pharmacol; 1983 Apr; 32(8):1347-52. PubMed ID: 6574748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.